ORBIMED ADVISORS LLC

13F Portfolio Filings

Latest 13F report
Q2 2024 - Aug 14, 2024
Value $
$4.66B
Signature - Title
Sven H. Borho - Member
Location
601 Lexington Avenue, 54 Th Floor, New York, New York
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 108 $4.66B +$364M -$624M -$260M LLY, EWTX, BSX, ISRG, BIIB 13F-HR 8/14/2024, 04:06 PM
Q1 2024 112 $5.07B +$671M -$958M -$287M LLY, EWTX, BSX, ISRG, BIIB 13F-HR 5/15/2024, 04:12 PM
Q4 2023 109 $4.99B +$462M -$837M -$375M SVA, BIIB, LLY, BSX, ISRG 13F-HR 2/14/2024, 04:14 PM
Q3 2023 120 $4.32B +$549M -$718M -$168M BSX, HUM, ISRG, BIIB, BMRN 13F-HR 11/14/2023, 04:14 PM
Q2 2023 119 $5.07B +$660M -$493M +$167M ISRG, ELVN, BSX, THRX, BIIB 13F-HR 8/14/2023, 04:25 PM
Q1 2023 116 $5.05B +$741M -$755M -$14.1M SVA, ELVN, BSX, HUM, BMY 13F-HR 5/15/2023, 04:41 PM
Q4 2022 114 $5.17B +$444M -$709M -$265M SVA, UNH, BMY, BSX, HUM 13F-HR 2/14/2023, 04:07 PM
Q3 2022 128 $4.97B +$677M -$967M -$290M BMY, HUM, SWTX, BSX, BMRN 13F-HR 11/14/2022, 04:11 PM
Q2 2022 138 $5.15B +$263M -$496M -$233M BMY, HUM, HZNP, BSX, TPTX 13F-HR 8/15/2022, 04:31 PM
Q1 2022 142 $6.16B +$688M -$1.09B -$402M SWTX, HZNP, BSX, PFE, THRX 13F-HR 5/16/2022, 04:17 PM
Q4 2021 156 $7.56B +$983M -$1.18B -$196M SWTX, BMY, HZNP, BSX, THRX 13F-HR 2/14/2022, 04:29 PM
Q3 2021 165 $8.76B +$1.03B -$821M +$208M SWTX, PRLD, HZNP, MRK, BMY 13F-HR 11/15/2021, 04:05 PM
Q2 2021 153 $9.54B +$959M -$637M +$322M SWTX, BMY, EWTX, BSX, MRK 13F-HR 8/16/2021, 04:14 PM
Q1 2021 151 $10.2B +$2.04B -$2B +$39.6M SWTX, EWTX, PRLD, SPRY, HZNP 13F-HR 5/17/2021, 04:16 PM
Q4 2020 146 $11.3B +$2.22B -$821M +$1.4B PRLD, SWTX, PMVP, SPRY, ABCL 13F-HR 2/16/2021, 04:43 PM
Q3 2020 138 $7.83B +$1.71B -$696M +$1.02B PRLD, SWTX, PMVP, ALXN, TPTX 13F-HR 11/16/2020, 04:12 PM
Q2 2020 130 $7.05B +$1.1B -$1.18B -$77.6M SWTX, TCDAQ, ALXN, ASND, PRVL 13F-HR 8/14/2020, 04:54 PM
Q1 2020 138 $5.91B +$1.47B -$1.52B -$46.9M ASND, TCDAQ, ALEC, SWTX, MRK 13F-HR 5/15/2020, 04:25 PM
Q4 2019 132 $6.98B +$1.08B -$1.06B +$27.1M ASND, THOR, TCDAQ, SWTX, PRVL 13F-HR 2/14/2020, 04:27 PM
Q3 2019 108 $5.22B +$523M -$987M -$464M ASND, TCDAQ, BSX, ALEC, PRVL 13F-HR 11/14/2019, 04:09 PM
Q2 2019 119 $6.34B +$886M -$954M -$67.9M ASND, TCDAQ, BSX, ALXN, ALEC 13F-HR 8/14/2019, 04:57 PM
Q1 2019 117 $6.38B +$1.09B -$1.33B -$245M ASND, TCDAQ, CMTA, ALXN, ALEC 13F-HR 5/15/2019, 04:24 PM
Q4 2018 125 $5.36B +$655M -$2.13B -$1.48B TCDAQ, ASND, BIIB, CELG, BSX 13F-HR 2/14/2019, 04:35 PM
Q3 2018 146 $8.27B +$1.04B -$1.56B -$518M ALXN, TCDAQ, BIIB, VRTX, BSX 13F-HR 11/14/2018, 04:07 PM
Q2 2018 140 $8.33B +$1.46B -$1.46B -$6.28M ALXN, BIIB, TCDAQ, BSX, VRTX 13F-HR 8/14/2018, 04:01 PM
Q1 2018 130 $8.01B +$1.75B -$1.68B +$71.1M ALXN, REGN, VRTX, MRK, BIIB 13F-HR 5/15/2018, 04:14 PM
Q4 2017 127 $7.76B +$501M -$2.62B -$2.12B BIIB, ALXN, REGN, CELG, VRTX 13F-HR 2/14/2018, 04:31 PM
Q3 2017 136 $10.4B +$1.06B -$812M +$247M ALXN, BIIB, CELG, BSX, MRK 13F-HR 11/14/2017, 05:19 PM
Q2 2017 134 $9.5B +$1.46B -$1.22B +$241M ALXN, CELG, BIIB, BSX, MRK 13F-HR 8/14/2017, 04:27 PM
Q1 2017 131 $8.79B +$1.03B -$946M +$87.9M ALXN, BIIB, CELG, BSX, MRK 13F-HR 5/15/2017, 04:17 PM
Q4 2016 128 $7.79B +$1.21B -$1.41B -$202M ALXN, BIIB, CELG, BSX, AMGN 13F-HR 2/14/2017, 04:25 PM
Q3 2016 134 $8.71B +$1.09B -$2.6B -$1.51B BIIB, BSX, AMGN, ALXN, CELG 13F-HR 11/14/2016, 04:27 PM
Q2 2016 132 $9.48B +$1.19B -$1.48B -$293M BSX, AMGN, ABBV, BMY, BIIB 13F-HR 8/15/2016, 04:16 PM
Q1 2016 138 $9.47B +$1.06B -$865M +$196M BMY, HCA, AMGN, BSX, ABBV 13F-HR 5/16/2016, 04:20 PM
Q4 2015 128 $11B +$1.32B -$997M +$324M BMY, AMGN, BSX, AGN, BIIB 13F-HR 2/16/2016, 04:24 PM
Q3 2015 129 $9.89B +$1.12B -$1.06B +$53.5M BMY, HCA, AMGN, BSX, AGN Restatement 11/18/2015, 04:02 PM
Q2 2015 1 $1.66M $0 $0 BONE New Holdings 8/20/2015, 02:30 PM
Q2 2015 125 $11.8B +$2.31B -$2.06B +$245M BIIB, BMY, AGN, HCA, ABBV 13F-HR 8/14/2015, 04:22 PM
Q1 2015 125 $11.5B +$1.38B -$1.44B -$61.2M BMY, BIIB, AMGN, B108PS, CELG 13F-HR 5/15/2015, 04:31 PM
Q4 2014 121 $10.3B +$1.03B -$659M +$369M BIIB, BMY, AMGN, CELG, GILD 13F-HR 2/13/2015, 04:13 PM
Q3 2014 119 $9.11B +$1.64B -$989M +$655M GILD, BIIB, BMY, AMGN, ICPT 13F-HR 11/14/2014, 04:15 PM
Q2 2014 115 $8.25B +$1.04B -$753M +$288M ICPT, BMY, BIIB, ABBV, GILD 13F-HR 8/14/2014, 04:23 PM
Q1 2014 119 $7.86B +$1.21B -$1.02B +$190M ICPT, GILD, BIIB, BMY, RLYP 13F-HR 5/15/2014, 04:26 PM
Q4 2013 110 $6.71B $0 $0 GILD, BIIB, CELG, BMY, AMGN 13F-HR 2/14/2014, 04:25 PM